RPL17 and hypothyroidism: The incidence of hypothyroidism in patients whohad normal thyroid function at baseline was 12.1% (4/33), which was similar tothat of other anti-PD-1 antibodies.12 All the patients with hypothyroidism had nosymptoms and were successfully treated with replacement therapy.